Building U.S. Exposure
-
Upload
tmx-equicom -
Category
Documents
-
view
308 -
download
1
description
Transcript of Building U.S. Exposure
Building U.S. Exposure
What we hear
No one understands
my storyI am
undervalued
I can’t find buyers
I need access to more capital
$11 trillion in mutual fund assets
48% of global AUM
Canada = 2% of global mutual funds
U.S. Capital Markets
The world’s largest pool of capital is next door
Accessing the U.S.
Where do I start?
When is the right time to start?
Who do I call?
How much time will this take?
U.S. investors are active here
of all trading on the TSX is international
%40billion
$285of trading comes from the U.S.
What kind of profile do you have south of the border?
Attracting investment
SELLside
BUYSIDE
IR consultants
ISSUER
Specialization
general industry coverage niche specific
general industry coverage drill down specific
generalists industry specific
resources & everything else generalists, industry specific
& niche specific
Bankers
Analysts
Sales
Buy side
Retail brokers cannot proactively solicit clients to invest
Requires Blue Sky statute eligibility
S&P Corporation Records program
• 38 States, excluding CA and NY
What about retail?
•Social media•Traditional media channels
Ground upstrategy
Financial centers
San Francisco
Montreal
CalgaryVancouver
New York
BostonToronto
Chicago
Los Angeles
Minneapolis
Denver
MiamiHouston
Noel BrownManaging Director of Healthcare Investment Banking
Alger BoyerManaging Director of Institutional Sales & Trading
Jeff HooPrincipal, Lead Micro-cap Portfolio Manager and Senior Analyst
Panelists
How does the process of building your profile in the U.S. capital markets begin?
What is the most effective way for a Canadian issuer to gain the attention of U.S. investors?
When does it make sense for an issuer to try to gain the attention of U.S. investors?
What are the typical liquidity and market cap levels a U.S. investor needs to see for an
investment consideration?
Is a U.S. listing the answer to a Canadian issuers problems?
Is it possible to gain research coverage from a U.S. analyst without that listing?
How does the buy side differ in the U.S. versus Canada? Should I tailor my story to
the U.S. audience?
Questions?
Thank you!